Abbott extends change-in-control agreements with named executive officers through Dec 2024

ABBOTT LABORATORIES

Extension moves expiration date from Dec 31, 2022 to Dec 31, 2024 for named executive officers.
Agreements provide severance and other benefits upon a change in control of the company.
Previously reported Agreements with executive officers extended by two years effective Oct 18, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.